In vitro studies of 1-oxacephalosporin (LY 127935), a new beta-lactam antibiotic.
作者信息
Weaver S S, LeBlanc B M, Bodey G P
出版信息
Antimicrob Agents Chemother. 1980 Jan;17(1):92-5. doi: 10.1128/AAC.17.1.92.
Abstract
摘要
相似文献
1
In vitro studies of 1-oxacephalosporin (LY 127935), a new beta-lactam antibiotic.
Antimicrob Agents Chemother. 1980 Jan;17(1):92-5. doi: 10.1128/AAC.17.1.92.
2
[Bacteriological investigations with a new Semisynthetic oxy-beta-lactam antibiotic LY 127935 (AUTHOR'S TRANSL)].
Infection. 1980;8(1):43-5. doi: 10.1007/BF01677399.
3
Comparative in vitro activity of LY 127935 (6059-S), seven cephalosporins, three aminoglycosides, carbenicillin, and ticarcillin.
J Antibiot (Tokyo). 1979 Oct;32(10):1019-24. doi: 10.7164/antibiotics.32.1019.
4
In-vitro activity of the novel oxa-beta-lactam antibiotic moxalactam (LY 127935) against dense populations of selected Gram-negative bacilli.
J Antimicrob Chemother. 1981 Apr;7(4):353-62. doi: 10.1093/jac/7.4.353.
5
In vitro evaluation of LY127935, a new beta-lactam antibiotic with broad-spectrum activity.
J Antimicrob Chemother. 1980 Jul;6(4):495-8. doi: 10.1093/jac/6.4.495.
6
Comparative susceptibilities of Pseudomonas aeruginosa to 1-oxacephalosporin (LY 127935) and eight other antipseudomonal antimicrobial agents (old and new).
Antimicrob Agents Chemother. 1980 Jan;17(1):96-8. doi: 10.1128/AAC.17.1.96.
7
LY127935, a novel oxa-beta-lactam: an in vitro comparison with other beta-lactam antibiotics.
Antimicrob Agents Chemother. 1979 Sep;16(3):341-5. doi: 10.1128/AAC.16.3.341.
8
In vitro and in vivo antibacterial activity of moxalactam, an oxa-beta-lactam antibiotic.
Rev Infect Dis. 1982 Nov-Dec;4 Suppl:S501-10. doi: 10.1093/clinids/4.supplement_3.s501.
9
Ro 13-9904 and GR 20263, two new cephalosporins with broad-spectrum activity: an in vitro comparison with other beta-lactam antibiotics.
J Antimicrob Chemother. 1981 May;7(5):515-20. doi: 10.1093/jac/7.5.515.
10
In vitro comparison of third-generation cephalosporins, piperacillin, dibekacin, and other aminoglycosides against aerobic bacteria.
Antimicrob Agents Chemother. 1981 Mar;19(3):490-2. doi: 10.1128/AAC.19.3.490.
引用本文的文献
1
Comparative in vitro study in new cephalosporins.
Antimicrob Agents Chemother. 1981 Aug;20(2):226-30. doi: 10.1128/AAC.20.2.226.
2
Comparative susceptibilities of clinical isolates of Serratia marcescens to newer cephalosporins, alone and in combination with various aminoglycosides.
Antimicrob Agents Chemother. 1980 Nov;18(5):651-5. doi: 10.1128/AAC.18.5.651.
3
[N-formimidoyl-thienamycin: in vitro activity in bacteria with resistance to beta-lactam antibiotics or gentamicin].
Infection. 1982 Nov-Dec;10(6):361-70. doi: 10.1007/BF01642300.
4
The third generation cephalosporins.
Bull N Y Acad Med. 1982 Nov;58(8):696-710.
5
Clinical pharmacology of moxalactam in patients with malignant disease.
Antimicrob Agents Chemother. 1981 Apr;19(4):639-44. doi: 10.1128/AAC.19.4.639.
6
Antagonism by chloramphenicol of broad-spectrum beta-lactam antibiotics against Klebsiella pneumoniae.
Antimicrob Agents Chemother. 1984 Apr;25(4):405-7. doi: 10.1128/AAC.25.4.405.
7
Moxalactam (latamoxef). A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Drugs. 1983 Oct;26(4):279-333. doi: 10.2165/00003495-198326040-00001.
8
Clinical evaluation of moxalactam: evidence of decreased efficacy in gram-positive aerobic infections.
Antimicrob Agents Chemother. 1983 Apr;23(4):565-70. doi: 10.1128/AAC.23.4.565.
9
Moxalactam therapy of bacterial meningitis in adults.
Antimicrob Agents Chemother. 1983 Feb;23(2):289-92. doi: 10.1128/AAC.23.2.289.
10
Randomized comparative study of moxalactam and cefazolin in the treatment of acute urinary tract infections in adults.
Antimicrob Agents Chemother. 1982 Jul;22(1):32-5. doi: 10.1128/AAC.22.1.32.
本文引用的文献
1
Resistance of gram-negative bacilli to gentamicin.
J Infect Dis. 1971 Dec;124 Suppl:S264-70. doi: 10.1093/infdis/124.supplement_1.s264.
2
Amikacin therapy of severe infections produced by gram-negative bacilli resistant to gentamicin.
Am J Med Sci. 1977 Mar-Apr;273(2):177-84. doi: 10.1097/00000441-197703000-00007.
3
BL-S786 (ceforanide), a new parenteral cephalosporin: in vitro studies.
Antimicrob Agents Chemother. 1979 Feb;15(2):318-22. doi: 10.1128/AAC.15.2.318.
4
HR 756, a new cephalosporin active against gram-positive and gram-negative aerobic and anaerobic bacteria.
Antimicrob Agents Chemother. 1979 Feb;15(2):273-81. doi: 10.1128/AAC.15.2.273.
5
Antibacterial activity of a new 1-oxa cephalosporin compared with that of other beta-lactam compounds.
Antimicrob Agents Chemother. 1979 Aug;16(2):141-9. doi: 10.1128/AAC.16.2.141.
Zotero 插件